NDC 0078-0716 – Tabrecta

Capmatinib Hydrochloride 200 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0078-0716

Product details

Brand name
Tabrecta
Generic name
Capmatinib
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA213591
Marketed since
May 6, 2020
Listing expires
December 31, 2026
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Tabrecta →

Package NDC codes (2)

Package NDCDescriptionSince
0078-0716-5656 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56)May 6, 2020
0078-0716-94 sample56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94)May 6, 2020

Other Tabrecta products